In our study, we found that the serum concentration of Smad4 in poorly differentiated NSCLC was in turn lower than that of moderately differentiated and well differentiated NSCLC, which implies that Smad4 plays a potential role in the disease progression of NSCLC. Here, SMAD4 is linked to non-small cell lung carcinoma.